Published in Women's Health Weekly, July 20th, 2006
Study 1: Breast cancer outcome might improve after primary systemic chemotherapy in patients who achieved a pathologic complete response (pCR) from metastases.
According to recent research from the United States, "Breast carcinoma axillary lymph node (ALN) pCR after primary chemotherapy is associated with significantly higher recurrence-free survival (RFS) and overall survival (OS) rates. The purpose of the current study was to determine long-term outcome in patients achieving a pCR of cytologically proven inflammatory breast carcinoma ALN metastases after primary...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.